Australia's most trusted
source of pharma news
Monday, 27 July 2026
Posted 27 July 2026 PM
It's been a "hell of a ride" for Adam Wyldeck but after two years in the US and more than five years at Johnson & Johnson, the Australian Communications and Public Affairs leader is leaving the company for a new plum role.
Full details on his next move are still under wraps but he has nabbed a new job at another Big Pharma and will remain in the US, leading Corporate Affairs for the company's US commercial business.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.